Skip to content

Common Sensing and Right Ventricular Automatic Capture (COGNATE)

Common Sensing and Right Ventricular Automatic Capture

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01030705
Acronym
COGNATE
Enrollment
80
Registered
2009-12-11
Start date
2009-11-30
Completion date
2010-06-30
Last updated
2011-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradycardia, Chronotropic Incompetence

Keywords

Bradycardia, pacemaker

Brief summary

This study will collect data on features for future pacemakers via an external non-implantable system.

Detailed description

COGNATE is an acute, confirmatory prospective, multi-center study designed to gather data on Brady and CRT-P indicated patients, with no restrictions on the type/brand of leads. This study will enroll up to 80 patients in up to 12 centers. Total duration of the study is expected to be 9 months.

Interventions

None listed

Sponsors

University of Pittsburgh
CollaboratorOTHER
Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are scheduled to receive either Pacemaker (dual chamber) or CRT-P devices based on physician discretion * Patients who are willing and capable of participating in all testing associated with this Clinical Investigation * Patients who are age 18 or above, or of legal age to give informed consent specific to state and national law

Exclusion criteria

* Patient enrolled in any concurrent study, without Boston Scientific CRM written approval, that may confound the results of this study * Patients with a prosthetic mechanical tricuspid heart valve * Women who are pregnant

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026